Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)
Shari S. Bassuk(Cosmos Corporation (United States)), Julie E. Buring(Brigham and Women's Hospital), I‐Min Lee(Brigham and Women's Hospital), Jean MacFadyen(Brigham and Women's Hospital), JoAnn E. Manson(Brigham and Women's Hospital), Georgina Friedenberg(Brigham and Women's Hospital), Claire Ridge(Brigham and Women's Hospital), Nancy R. Cook(Brigham and Women's Hospital), William G. Christen(Brigham and Women's Hospital), David Gordon(NYU Langone Health), Denise D’Agostino(Brigham and Women's Hospital), Kate Kalan(Brigham and Women's Hospital), Trisha Copeland(Brigham and Women's Hospital), Vadim Bubes
Cited by 100
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
|The Journal of Clinical Endocrinology & Metabolism|2010|4k
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
|New England Journal of Medicine|2002|3.6k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k